Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy

@article{Evans2004PharmacogeneticsOT,
  title={Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy},
  author={W. Evans},
  journal={Therapeutic Drug Monitoring},
  year={2004},
  volume={26},
  pages={186-191}
}
  • W. Evans
  • Published 2004
  • Biology, Medicine
  • Therapeutic Drug Monitoring
  • Abstract: Most medications exhibit wide interpatient variability in their efficacy and toxicity. For many medications, these interindividual differences result in part from polymorphisms in genes encoding drug-metabolizing enzymes, drug transporters, and/or drug targets (eg, receptors, enzymes). Pharmacogenomics is a burgeoning field aimed at elucidating the genetic basis of differences in drug efficacy and toxicity, using genome-wide approaches to identify the network of genes that govern an… CONTINUE READING
    189 Citations
    Clinical pharmacology and pharmacogenetics of thiopurines
    • 301
    Preparing for the Genomic Age: Thiopurine S-Methytransferase Polymorphism
    Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    • T. Bosch
    • Medicine
    • Methods in molecular biology
    • 2008
    • 48
    Pharmacogenetics in inflammatory bowel disease.
    • 35

    References

    SHOWING 1-10 OF 58 REFERENCES
    Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    • 389
    • PDF
    Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
    • 643
    • PDF
    Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms
    • 390
    Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
    • 362
    Drug methylation in cancer therapy: lessons from the TPMT polymorphism
    • 123
    • PDF